期刊
NANO TODAY
卷 37, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2020.101073
关键词
Photothermal therapy; Near-infrared; Cancer therapy; Synergistic action; Nanomedicines
资金
- Program for International S&T Cooperation Projects of the Ministry of Science and Technology of China [2018YFE0117200]
- National Natural Science Foundation of China [81903165]
Cancer nanomedicines offer promising treatment strategies, with photothermal therapy identified as a safe modality for achieving photothermal synergistic cancer therapy and significantly improved benefits.
Cancer nanomedicines have provided promising treatment strategies for the regression of several types of cancer, although there still exists a need for significant advances to improve their therapeutic outcomes and reduce side effects. In this context, photothermal therapy (PTT) that uses near-infrared (NIR) photoirradiation of photothermal agents to generate heat for localized thermal damages has been established as a safe therapeutic modality. In addition to direct ablation of tumors, the heat generated during PTT process can achieve on-demand release of other therapeutic compounds, regulation of gene transcription and enzyme activity and enhancement of chemical reactions in tumor tissues, thereby resulting in photothermal synergistic cancer therapy with obviously improved benefits. In this review, we summarize the recent developments in NIR photoactivated nanomedicines for photothermal synergistic cancer therapy. We introduce the designing principles and the working mechanisms of nanoparticles upon NIR photoirradiation and their applications in photothermal synergistic chemotherapy, enzyme therapy, gene therapy, photodynamic therapy, chemodynamic therapy, thermodynamic therapy, immunotherapy and their multimodal therapies for cancer. Moreover, we discuss the existing challenges and further perspectives in this field. (C) 2021 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据